Every 10-Q that JBT Marel Corporation (JBTM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow JBTM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JBTM filings page.
JBT Marel Corporation, a global food and beverage technology provider, reported stronger results for the quarter and six months ended June 30, 2026. Second‑quarter revenue rose to $981 million, up 4.9% year over year, with growth in both recurring and project-related sales and a tailwind from foreign exchange. Gross margin improved to 36.6% from 35.8%, helped by tariff recoveries, higher volumes and better fixed‑cost leverage, partly offset by inflation.
Quarterly net income increased to $28 million (diluted EPS $0.54) versus $3 million a year earlier, while Adjusted EBITDA rose to $168 million with a 17.1% margin. For the first six months, revenue reached $1.917 billion, net income was $73 million versus a $170 million loss in 2025, and Adjusted EBITDA was $310 million with a 16.2% margin, driven by higher volume, lower acquisition‑ and pension‑related costs, and a sharp drop in interest expense.
Protein Solutions led growth, with Q2 revenue up 10.9% to $467 million and Adjusted EBITDA margin expanding to 24.0%. Prepared Food and Beverage Solutions revenue was flat at $514 million, with margin easing to 17.5% amid operational inefficiencies and inflation. Operating cash flow strengthened to $221 million for the half. Total debt was $1.679 billion at June 30, 2026, after repayment of $403 million of 2026 convertible notes. The company recorded a $33 million intangible impairment in Protein Solutions and has incurred $41 million of cumulative restructuring charges under its JBT Marel 2025 Integration plan, targeting $55–$60 million in total. Management highlights a record backlog and $1.5 billion of remaining performance obligations and continues to expect full‑year 2026 growth in revenue, margins and earnings per share.
JBT Marel Corporation reported a sharp turnaround for the three months ended March 31, 2026, with revenue of $936 million, up 9.6% from 2025, and net income of $45 million versus a prior-year loss of $173 million. Gross margin improved to 35.1% as synergy benefits and higher volumes more than offset higher tariff costs.
Selling, general and administrative expenses fell significantly, aided by the JBT Marel 2025 Integration restructuring plan and lower M&A costs. Adjusted EBITDA rose to $142 million with a 15.2% margin. Operating cash flow strengthened to $119 million, and free cash flow reached $100 million. Total debt stood at $1.84 billion, including convertible notes maturing in 2026 and 2030, while cash and cash equivalents were $211 million.
JBT Marel Corporation (NYSE: JBTM) reported Q3 2025 results reflecting the first full quarters with Marel. Revenue rose to $1,001.3 million from $453.8 million a year ago, and operating income increased to $102.1 million from $46.8 million. Net income was $66.0 million versus $38.9 million in Q3 2024, while diluted EPS was $1.26 versus $1.21.
For the first nine months, the company posted a net loss of $103.6 million, driven by a $146.9 million pension settlement charge, acquisition-related costs, and higher interest expense. Cash from continuing operations was $224.3 million. Cash, cash equivalents and restricted cash ended at $133.3 million.
JBT closed the $4.27 billion Marel acquisition on January 2, 2025, recognizing $2.31 billion of goodwill and $2.62 billion of intangible assets at September 30, 2025. Total assets were $8,199.4 million and equity was $4,420.8 million. Debt totaled $1,905.4 million, including a $900 million Term Loan B and $575.0 million of 2030 convertible notes. Shares outstanding were 51,971,372 as of October 30, 2025. The company corrected immaterial cash flow presentation errors from earlier 2025 periods.